Bioadaptives (BDPT) Short-term Investments (2013 - 2023)

Bioadaptives has disclosed Short-term Investments across 10 years of filings, most recently posting $11.0 for Q3 2023.

• Short-term Investments for Q3 2023 came in at $11.0, down 65.62% year-over-year; the trailing twelve-month figure through Sep 2023 was $11.0 (down 65.62% YoY), and the FY2022 annual result was $42.0, down 77.89% from the prior year.
• Short-term Investments came in at $11.0 for Q3 2023 at Bioadaptives, down from $21.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $3278.0 in Q1 2021 to a low of $11.0 in Q3 2023.
• The 5-year median for Short-term Investments is $264.0 (2021), against an average of $556.83.
• Across the five-year window, Short-term Investments sank 96.3% in 2020 and surged 1107.94% in 2021, its largest moves.
• Bioadaptives' Short-term Investments stood at $772.0 in 2019, then sank by 42.49% to $444.0 in 2020, then sank by 57.21% to $190.0 in 2021, then slumped by 77.89% to $42.0 in 2022, then sank by 73.81% to $11.0 in 2023.
• The last three Short-term Investments figures came in at $11.0 (Q3 2023), $21.0 (Q2 2023), and $32.0 (Q1 2023), per Business Quant data.